Breaking News

Freudenberg Medical Invests $50M in New Production Facility in Germany

Will serve as a hub for research, development, and production, driving innovation in medical coatings.

Author Image

By: Charlie Sternberg

Associate Editor

Freudenberg Medical, a global contract design and manufacturing (CDMO) partner to the medical device and biopharma industry, is further expanding its drug device combination products business by investing more than $50 million in a new Hemoteq AG production facility in Aachen, Germany, an important life science hotspot.   Freudenberg Medical grew its portfolio to include drug coating solutions for balloon catheters and stents as well as hydrophilic coatings when it acquired Hemoteq in 2015.  ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters